Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.Journal of Magnetic Resonance Imaging : JMRI|February 15, 2021
Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast CancerBenjamin C Musall, Abeer H Abdelhafez, Beatriz E Adrada, et al.Breast Cancer Research and Treatment|September 13, 2020
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC)Abeer H Abdelhafez, Benjamin C Musall, Beatriz E Adrada, et al.Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.Nature Communications|September 11, 2021
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancerVrutant V Shah, Aundrietta D Duncan, Shiming Jiang, et al.Cancer Research Communications|October 2, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II StudyClinton Yam, Miral Patel, Holly A Hill, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast CancerAngela DeMichele, Douglas Yee, Donald A Berry, et al.The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast CancerHope S Rugo, Olufunmilayo I Olopade, Angela DeMichele, et al.The New England Journal of Medicine|July 14, 2016
Adaptive Randomization of Neratinib in Early Breast CancerJohn W Park, Minetta C Liu, Douglas Yee, et al.Pageof 9